Internal Medicine, Endocrinology, Diabetes, & Metabolism · Anchorage, AK
NPI
1184606014
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2841 Debarr Rd Ste 50
Anchorage, AK, 99508
Phone (907) 276-2811
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
1,877 services
Medicare patients, 2024
412
Average age 73
Drug cost, 2024
$352K
1,150 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Janice A Koval was code 99214 (office e&m - established), 398 times for 222 patients. In total Janice A Koval billed 1,877 services in 23 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 398 | 222 | $116.42 | $46K |
| 99213 Office E&M - Established | Office | 295 | 205 | $80.00 | $24K |
| 99204 Office E&M - New | Office | 19 | 19 | $152.59 | $2,899 |
| 99215 Office E&M - Established | Office | 16 | 16 | $169.42 | $2,711 |
By year: 2022 $83K for 1,770 services; 2023 $73K for 726 services; 2024 $99K for 1,877 services.
Medicare prescription drug claims, 2024
In 2024, the drug Janice A Koval prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 504 prescriptions and refills. In total Janice A Koval wrote 1,150 Medicare prescriptions that cost $352K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 504 | 1,397 | 123 | $60K |
| Levothyroxine Sodium Generic | 69 | 200 | 22 | $661 |
| Methimazole Generic | 57 | 148 | 16 | $939 |
| Tirosint Levothyroxine Sodium | 54 | 153 | 17 | $20K |
| Metformin Hcl Er Metformin Hcl | 53 | 147 | 16 | $1,052 |
| Alendronate Sodium Generic | 31 | 84 | 11 | $6,029 |
| Ozempic Semaglutide | 26 | 53 | Under 11 | $51K |
| Tresiba Flextouch U-100 Insulin Degludec | 23 | 71 | Under 11 | $17K |
| Hydrocortisone Generic | 17 | 50 | Under 11 | $814 |
| Cabergoline Generic | 16 | 40 | Under 11 | $1,214 |
| Mounjaro Tirzepatide | 15 | 29 | Under 11 | $32K |
| Atorvastatin Calcium Generic | 14 | 42 | Under 11 | $174 |
| Tirosint-Sol Levothyroxine Sodium | 13 | 28 | Under 11 | $3,770 |
| Liothyronine Sodium Generic | 13 | 39 | Under 11 | $758 |
| Humalog Insulin Lispro | 12 | 35 | Under 11 | $2,777 |
Brand drugs: 815 claims; generic drugs: 293 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Janice A Koval were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.